CD56+ putative natural killer cell lymphomas: Production of cytolytic effectors and related proteins mediating tumor cell apoptosis?

Human Pathology

Volumn 28, Issue 11, 1997, Pages 1276-1282

  Ng, Chi Sing ^a   Lo, Stephen T H ^b   Chan, John K C ^b   Chan, Wing C ^b  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

^b NONE

Author keywords

Apoptosis; Cytolytic markers; NK lymphomas

Indexed keywords

CD56 ANTIGEN; CD8 ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; NATURAL KILLER CELL;

EID: 0030779516     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90201-X     Document Type: Article

References (56)

1. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
2. Kimura KI, Truman JW: Postmetamorphic cell death in the nervous and muscular systems of Drosophila melanogaster. J Neurosci 10:403-411, 1990
3. Green DR, Scott DW: Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6:676-687, 1994
4. Fujiwara T, Grimm EA, Mukhopadhyay T, et al: A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by apoptosis. Cancer Res 53:4129-4133, 1993
5. Kerr JFR, Wintcrford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013-2026, 1994
6. Sarkiss M, Hsu B, El-Naggar AK, et al: The clinical relevance and assessment of apoptotic cell death. Adv Anat Pathol 3:205-211, 1996
7. Evan GI, Wyllie AH, Gilbert CS, et al: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992
8. Lowe SW, Schmitt EM, Smith GW, et al: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993
9. Vaux DL, Cory S, AdamsJM: bc1-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortolize pre-B cells. Nature 335:440-442, 1988
10. Hockenbery D, Nunez G, Milliman C, et al: bc1-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
11. Lowin B, Peitsch MC, Tschopp J: Perform and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity: Pathways of Cytolysis. Curr Top Microbiol Immunol 198:1-23, 1995
12. Goldstein P: Fas-based T cell-mediated cytotoxicity: Pathways of cytolysis. Curr Top Microbiol Immunol 198:25-37, 1995
13. Greenberg AH, Litchfield DW: Granzymes and apoptosis: Targeting the cell cycle: Pathways of cytolysis. Curr Top Microbiol Immunol 198:95-119, 1995
14. Podack ER: Perform, killer cells and gene transfer immunotherapy for cancer: Pathways of cytolysis. Curr Top Microbiol Immunol 198:121-129, 1995
15. Anderson P: TIA1: Structural and functional studies on a new class of cytolytic effector molecules: Pathways of cytolysis. Curr Top Microbiol Immunol 198:131-143, 1995
16. Liu CC, Walsh CM, Young JDE: Perform: Structure and function. Immunol Today 16:194-201, 1995
17. Smyth MJ, Trapani JA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202-206, 1995
18. Tian Q, Streull M, Salto H, et al: A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629-639, 1991
19. Medley QG, Kedersha N, O'Brien S, et al: Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci 93:685-689, 1996
20. Ng CS, Chan JKC, Lo STH: Expression of natural killer cell markers in non-Hodgkin's lymphomas. HUM PATHOL 18:1257-1262, 1987
21. Chan JKC, Ng CS, Lau WH, et al: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429, 1987
22. Ho FCS, Choy D, Loke SL: Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. HUM PATHOL 21:1041-1050, 1990
23. Kanavaros P, Lescs MC, Briere J: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688-2695, 1993
24. 1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol 132:365-371, 1988
25. Jaffe ES, Chan JKC, Su IJ, et al: Report of the Workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis and epidemiology. Am J Surg Pathol 20:103-111, 1996
26. Van Gorp J, Liu WP, Jacobse K: Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 173:81-87, 1994
27. Strickler JG, Meneses MF, Habermann TM: Polymorphic reticulosis: A reappraisal. HUM PATHOL 25:659-665, 1994
28. Weiss LM, Picker LJ, Grogan TM, et al: Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 130:436-442, 1988
29. Medeiros LJ, Peiper SC, Elwood L, et al: Angiocentric immunoproliferative lesions: A molecular analysis of eight cases. HUM PATHOL 22:1150-1157, 1991
30. Ho FCS, Srivastava G, Loke SL: Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol 8:271-281, 1990
31. Chan JKC, Yip TTC, Tsang WYW, et al: Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 18:938-946, 1994
32. Tsang WYW, Chan JKC, Yip TTC, et al: In situ localization of Epstein-Barr viral encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. HUM PATHOL 25:758-765, 1994
33. Arber DA, Weiss LM, Albujar PF, et al: Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:392-399, 1993
34. Wong KF, Chan JKC, Ng CS, et al: CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. HUM PATHOL 23:798-804, 1992
35. Kern WF, Spier CM, Hauneuman EH, et al: Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 79:2432-2437, 1992
36. Wong KF, Chan JKC, Ng CS: CD56 (NCAM)-positive malignant lymphomas (Invited Review). Leuk Lymphoma 14:29-36, 1994
37. Nokumura S, Suchi T, Koshikawa T: Clinicopathologic study of CD56 (NCAM) positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 19:284-296, 1995
38. Chan JKC, Tsang WYW, Lau WH, et al: Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 77:1198-1205, 1996
39. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87:1466-1473, 1996
40. de Bruin PC, Kummer JA, van der Valk P, et al: Granzyme B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T-cell with preference for mucosa-associated lymphoid tissue localization. Blood 84:3785-3791, 1994
41. Takeshita M, Kimura N, Suzumiya J, et al: Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch 425:499-504, 1994
42. Martin AR, Chan WC, Perry DA, et al: Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 8:467-472, 1995
43. Mori N, Yatabe Y, Oka K, et al: Expression of perform in nasal lymphoma: Additional evidence of its natural killer cell derivation. Am J Pathol 149:699-705, 1996
44. Petrella T, Delfau-Larue M-H, Caillot D, et al: Nasopharyngeal lymphomas: Further evidence for a natural killer cell origin. HUM PATHOL 27:827-833, 1996
45. Guesdon JL, Terynck T, Avrameas S: The use of avidin-biotin interaction in immunoenzyme techniques. J Histochem Cytochem 27:1131-1139, 1979
46. Tsang WYW, Chan JKC, Ng CS: Kikuchi's lymphadenitis, a morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol 18:219-231, 1994
47. Takakuwa T, Ohnuma S, Koike J, et al: Involvement of cellmediated killing in apoptosis in histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). Histopathology 28:41-48, 1996
48. McDonnell TJ: Cell division versus cell death: A functional model of multistep neoplasia. Mol Carcinog 8:209-213, 1993
49. Ikeda H, Hirato J, Akami M, et al: Massive apoptosis detected by in situ DNA nick end labelling in neuroblastoma. Am J Surg Pathol 20:649-655, 1996
50. Farber E: Programmed cell death: Necrosis versus apoptosis. Mod Pathol 7:605-609, 1994
51. Eischen CM, Schilling JD, Lynch DH, et al: Fc receptorinduced expression of Fas ligand on activated NK cells facilitates cellmediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 156:2693-2699, 1996
52. Mosialos G, Birkenbach M, Yalamanchili R, et al: The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 80:389-399, 1995
53. Flier JS, Underhill LH: The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725, 1996
54. Tanaka M, Suda T, Haze K, et al: Fas ligand in human serum. Nat Med 2:317-322, 1996
55. Sato K, Kimura F, Nakamura Y, et al: An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. Br J Haematol 94:379-382, 1996
56. + putative natural killer (NK) cell lymphomas frequently coexpress Fas and Fas-ligand (FasL). Mod Pathol, 10:131, 1997 (abstr)